跳至主要内容
临床试验/NCT01443598
NCT01443598已完成不适用

Observational Study of Patients With Pre Capillary Pulmonary Hypertension

Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires1 个研究点 分布在 1 个国家目标入组 224 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
224
试验地点
1
主要终点
Overall survival

研究概览

简要总结

HYPID study is an observational and prospective study of patients with interstitial lung disease and pre capillary hypertension diagnosed by right heart sided catheterization. The primary aim of the study is to identify prognostic factors.

详细描述

Pre capillary pulmonary hypertension (PH) may be present in patients with diffuse interstitial lung disease.

In this context, PH represents an important factor of morbidity and mortality for these patients.

One of the purposes of HYPID is to determine predictive factors of mortality within this cohort of patients.

In order to reach that aim,the study includes an evaluation based on exams conducted for the routine follow-up of patients. Each patient will be followed during 2 years at least.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • pre capillary pulmonary hypertension at right heart sided catheterization with: mPAP > or = 25 mmHg,PCWP < or = 15 mmHg
  • interstitial lung disease with diffuse infiltrative opacities on chest CT scan

排除标准

  • pulmonary hypertension related to a thromboembolic disease
  • respiratory disease other than diffuse interstitial lung disease
  • any etiological factor of pulmonary arterial hypertension based on DANA POINT classification other than diffuse interstitial lung disease
  • any progressive disease associated to a life expectancy less than 6 months other than pulmonary hypertension, diffuse interstitial lung disease and respiratory insufficiency

结局指标

主要结局

Overall survival

时间窗: 2 years

Determine predictive factors of mortality

次要结局

  • Progression-free survival (1)(2 years)
  • Progression-free survival (2)(2 years)
  • Progression-free survival (3)(2 years)
  • Progression-free survival (6)(2 years)
  • Progression-free survival (4)(2 years)
  • Progression-free survival (5)(2 years)

研究者

发起方
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
申办方类型
Other
责任方
Principal Investigator
主要研究者

Vincent COTTIN

Professor V. Cottin

Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires

研究点 (1)

Loading locations...

相似试验